Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Neumora Therapeutics Employees
Neumora Therapeutics had 96 employees as of December 31, 2025. The number of employees decreased by 14 or -12.73% compared to the previous year.
Employees
96
Change (1Y)
-14
Growth (1Y)
-12.73%
Revenue / Employee
n/a
Profits / Employee
-$2,468,000
Market Cap
411.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Neurogene | 131 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
| Armata Pharmaceuticals | 60 |
| Lexeo Therapeutics | 59 |
NMRA News
- 15 days ago - Neumora Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 22 days ago - Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 27 days ago - NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 4 weeks ago - Neumora Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026 - GlobeNewsWire
- 2 months ago - Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment - Benzinga
- 2 months ago - Neumora Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts